Suppr超能文献

搅拌罐生物反应器中人类间充质干/基质细胞扩增过程中分泌蛋白的蛋白质组学鉴定及时间进程监测

Proteomic Identification and Time-Course Monitoring of Secreted Proteins During Expansion of Human Mesenchymal Stem/Stromal in Stirred-Tank Bioreactor.

作者信息

Mizukami Amanda, Thomé Carolina Hassibe, Ferreira Germano Aguiar, Lanfredi Guilherme Pauperio, Covas Dimas Tadeu, Pitteri Sharon J, Swiech Kamilla, Faça Vitor Marcel

机构信息

Faculty of Medicine of Ribeirão Preto, Hemotherapy Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.

Department of Biochemistry and Immunology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.

出版信息

Front Bioeng Biotechnol. 2019 Jun 26;7:154. doi: 10.3389/fbioe.2019.00154. eCollection 2019.

Abstract

The therapeutic potential of mesenchymal stem/stromal cells (MSC) is widely recognized for the treatment of several diseases, including acute graft-vs.-host disease (GVHD), hematological malignancies, cardiovascular, bone, and cartilage diseases. More recently, this therapeutic efficacy has been attributed to the bioactive molecules that these cells secrete (secretome), now being referred as medicinal signaling cells. This fact raises the opportunity of therapeutically using MSC-derived soluble factors rather than cells themselves, enabling their translation into the clinic. Indeed, many clinical trials are now studying the effects of MSC-secretome in the context of cell-free therapy. MSC secretome profile varies between donors, source, and culture conditions, making their therapeutic use very challenging. Therefore, identifying these soluble proteins and evaluating their production in a reproducible and scalable manner is even more relevant. In this work, we analyzed the global profile of proteins secreted by umbilical cord matrix (UCM) derived-MSC in static conditions by using mass spectrometry, enabling the identification of thousands of proteins. Afterwards, relevant proteins were chosen and monitored in the supernatant of a fully-controllable, closed and scalable system (bioreactor) by using multiple reaction monitoring (MRM) mass spectrometric technique in a time-dependent manner. The results showed that the majority of interesting proteins were enriched through time in culture, with the last day of culture being the ideal time for supernatant collection. The use of this regenerative "soup," which is frequently discarded, could represent a step toward a safe, robust and reproducible cell-free product to be used in the medical therapeutic field. The future use of chemically defined culture-media will certainly facilitate secretome production according to Good Manufacturing Practice (GMP) standards.

摘要

间充质干/基质细胞(MSC)在治疗多种疾病方面的治疗潜力已得到广泛认可,这些疾病包括急性移植物抗宿主病(GVHD)、血液系统恶性肿瘤、心血管疾病、骨骼疾病和软骨疾病。最近,这种治疗效果归因于这些细胞分泌的生物活性分子(分泌组),这些细胞现在被称为药用信号细胞。这一事实为治疗性使用MSC衍生的可溶性因子而非细胞本身提供了机会,从而使其能够转化应用于临床。事实上,现在许多临床试验正在研究无细胞治疗背景下MSC分泌组的作用。MSC分泌组的特征因供体、来源和培养条件而异,这使得它们的治疗应用极具挑战性。因此,识别这些可溶性蛋白质并以可重复和可扩展的方式评估其产量就显得更为重要。在这项工作中,我们通过质谱分析了脐带基质(UCM)来源的MSC在静态条件下分泌的蛋白质的整体特征,从而能够鉴定出数千种蛋白质。之后,选择相关蛋白质,并通过多反应监测(MRM)质谱技术在一个完全可控、封闭且可扩展的系统(生物反应器)的上清液中进行随时间变化的监测。结果表明,大多数感兴趣的蛋白质在培养过程中随时间富集,培养的最后一天是收集上清液的理想时间。使用这种通常被丢弃的再生“汤”,可能是朝着在医学治疗领域使用安全、稳定且可重复的无细胞产品迈出的一步。未来使用化学成分明确的培养基肯定会根据良好生产规范(GMP)标准促进分泌组的生产。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c783/6607109/c494066d769f/fbioe-07-00154-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验